These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17662093)

  • 21. Acid-base profile and predictors of metabolic acidosis in patients undergoing peritoneal dialysis with lactate- and bicarbonate-buffered peritoneal dialysis solutions.
    Fourtounas C; Savidaki E; Roumelioti M; Dousdampanis P; Hardalias A; Kalliakmani P; Papachristou E; Drakopoulos A; Goumenos DS; Vlachojannis JG
    Adv Perit Dial; 2006; 22():187-91. PubMed ID: 16983967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clearance of iopamidol, a non-ionic contrast medium, by CAPD in patients with end-stage renal failure.
    Donnelly PK; Burwell N; McBurney A; Ward JW; Walls J; Watkin EM
    Br J Radiol; 1992 Dec; 65(780):1108-13. PubMed ID: 1286420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.
    Knupp CA; Hak LJ; Coakley DF; Falk RJ; Wagner BE; Raasch RH; van der Horst CM; Kaul S; Barbhaiya RH; Dukes GE
    Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of effects of automated peritoneal dialysis and continuous ambulatory peritoneal dialysis on health-related quality of life, sleep quality, and depression.
    Guney I; Solak Y; Atalay H; Yazici R; Altintepe L; Kara F; Yeksan M; Turk S
    Hemodial Int; 2010 Oct; 14(4):515-22. PubMed ID: 20955286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of combination therapy with peritoneal dialysis and hemodialysis on peritoneal function.
    Moriishi M; Kawanishi H; Tsuchiya S
    Adv Perit Dial; 2010; 26():67-70. PubMed ID: 21348383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and safety of oseltamivir in patients with end-stage renal disease treated with automated peritoneal dialysis.
    Patel K; Rayner CR; Giraudon M; Kamal MA; Morcos PN; Robson R; Kirkpatrick CM
    Br J Clin Pharmacol; 2015 Apr; 79(4):624-35. PubMed ID: 25289522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis and peritonitis in the short and very long term at risk.
    Barone RJ; Cámpora MI; Gimenez NS; Ramirez L; Panese SA; Santopietro M
    Adv Perit Dial; 2012; 28():44-9. PubMed ID: 23311212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders.
    Bajo MA; del Peso G; Jiménez V; Aguilera A; Villar A; Jiménez C; Selgas R
    Adv Perit Dial; 2000; 16():170-3. PubMed ID: 11045286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of single-dose rosiglitazone in chronic ambulatory peritoneal dialysis patients.
    Aramwit P; Supasyndh O; Sriboonruang T
    J Clin Pharm Ther; 2008 Dec; 33(6):685-90. PubMed ID: 19138247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single dose pharmacokinetics of lamivudine in subjects with impaired renal function and the effect of haemodialysis.
    Johnson MA; Verpooten GA; Daniel MJ; Plumb R; Moss J; Van Caesbroeck D; De Broe ME
    Br J Clin Pharmacol; 1998 Jul; 46(1):21-7. PubMed ID: 9690945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokinetics.
    Gerig JS; Bolton ND; Swabb EA; Scheld WM; Bolton WK
    Kidney Int; 1984 Sep; 26(3):308-18. PubMed ID: 6542606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioiodine dosimetry in patients with end-stage renal disease receiving continuous ambulatory peritoneal dialysis therapy.
    Kaptein EM; Levenson H; Siegel ME; Gadallah M; Akmal M
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3058-64. PubMed ID: 10999786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of telbivudine in subjects with various degrees of renal impairment.
    Zhou XJ; Swan S; Smith WB; Marbury TC; Dubuc-Patrick G; Chao GC; Brown NA
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4231-5. PubMed ID: 17875994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of colistin methanesulfonate and formed colistin in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis.
    Koomanachai P; Landersdorfer CB; Chen G; Lee HJ; Jitmuang A; Wasuwattakul S; Sritippayawan S; Li J; Nation RL; Thamlikitkul V
    Antimicrob Agents Chemother; 2014; 58(1):440-6. PubMed ID: 24189256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of intraperitoneal fluconazole during continuous cycling peritoneal dialysis.
    Dahl NV; Foote EF; Searson KM; Fein JL; Kapoian T; Steward CA; Sherman RA
    Ann Pharmacother; 1998 Dec; 32(12):1284-9. PubMed ID: 9876807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pharmacokinetic analysis of cisplatin and 5-fluorouracil in a patient with esophageal cancer on peritoneal dialysis.
    Eads JR; Beumer JH; Negrea L; Holleran JL; Strychor S; Meropol NJ
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):333-8. PubMed ID: 26687170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of flecainide in a patient undergoing continuous ambulatory peritoneal dialysis.
    Bailie GR; Waldek S
    J Clin Pharm Ther; 1988 Apr; 13(2):121-4. PubMed ID: 3134365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of intraperitoneal cefepime in automated peritoneal dialysis.
    Elwell RJ; Frye RF; Bailie GR
    Perit Dial Int; 2005; 25(4):380-6. PubMed ID: 16022096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of ornidazole in patients with renal insufficiency; influence of haemodialysis and peritoneal dialysis.
    Merdjan H; Baumelou A; Diquet B; Chick O; Singlas E
    Br J Clin Pharmacol; 1985 Feb; 19(2):211-7. PubMed ID: 3986079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic profiles of ceftazidime after intravenous administration in patients undergoing automated peritoneal dialysis.
    Kim K; Hwang YH; Ro H; Oh YK; Kim MG; Yu KS; Shin KH; Jang IJ; Shin SG; Ahn C; Oh KH
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2523-7. PubMed ID: 21402833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.